Ask AI
ProCE Banner Activity

Conference to Clinic: Integrating CD38-Based Quadruplet Therapy Into Care of Transplant-Ineligible and Transplant-Eligible NDMM

Slideset

These downloadable slides summarize key clinical data on immune-based therapies targeting CD38 in the treatment of patients with newly diagnosed multiple myeloma regardless of transplant eligibility.

Released: July 21, 2025

Expiration: January 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi Genzyme.

Sanofi Genzyme